Royal Bank Of Canada Sarepta Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 585,989 shares of SRPT stock, worth $66.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

585,989

Previous 495,540 18.25%

Holding current value

$66.6 Million

Previous $78.3 Million 6.52%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $11.2 Million - $14.2 Million	90,449 Added 18.25%	585,989 $73.2 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $3.96 Million - $5.72 Million	34,934 Added 7.58%	495,540 $78.3 Million
Q1 2024 Nov 05, 2024	SELL	$93.7 - $141.53 $3.27 Million - $4.94 Million	-34,934 Reduced 7.05%	460,606 $59.6 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $33.1 Million - $50 Million	-353,423 Reduced 43.42%	460,606 $59.6 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $24.6 Million - $45.6 Million	365,234 Added 81.38%	814,029 $78.5 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $1.65 Million - $1.98 Million	16,051 Added 3.71%	448,795 $54.4 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $8.03 Million - $11.9 Million	75,504 Added 21.14%	432,744 $49.6 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $6.11 Million - $8.1 Million	51,945 Added 17.01%	357,240 $49.2 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $21.3 Million - $27.9 Million	211,138 Added 224.24%	305,295 $39.6 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $385,136 - $606,573	-5,087 Reduced 5.13%	94,157 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $1.91 Million - $2.7 Million	30,517 Added 44.4%	99,244 $7.44 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $307,351 - $440,074	-4,867 Reduced 6.61%	68,727 $5.37 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $687,869 - $884,937	-8,901 Reduced 10.79%	73,594 $6.63 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $6.69 Million - $9.38 Million	-101,433 Reduced 55.15%	82,495 $7.63 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $12.8 Million - $16 Million	183,928 New	183,928 $14.3 Million

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Sarepta Therapeutics, Inc. Transaction History